- Home
- GORV vs ANTX Comparison
GORV vs ANTX Comparison
Compare GORV & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GORV
- ANTX
- Stock Information
- Founded
- GORV 1976
- ANTX 2017
- Country
- GORV United States
- ANTX United States
- Employees
- GORV N/A
- ANTX N/A
- Industry
- GORV Retail-Auto Dealers and Gas Stations
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- GORV Consumer Discretionary
- ANTX Health Care
- Exchange
- GORV Nasdaq
- ANTX Nasdaq
- Market Cap
- GORV 31.8M
- ANTX 37.3M
- IPO Year
- GORV 2015
- ANTX 2022
- Fundamental
- Price
- GORV $0.26
- ANTX $1.13
- Analyst Decision
- GORV Hold
- ANTX Buy
- Analyst Count
- GORV 2
- ANTX 3
- Target Price
- GORV $2.00
- ANTX $2.00
- AVG Volume (30 Days)
- GORV 24.1M
- ANTX 249.8K
- Earning Date
- GORV 05-15-2025
- ANTX 05-13-2025
- Dividend Yield
- GORV N/A
- ANTX N/A
- EPS Growth
- GORV N/A
- ANTX N/A
- EPS
- GORV N/A
- ANTX N/A
- Revenue
- GORV $767,257,000.00
- ANTX N/A
- Revenue This Year
- GORV $15.65
- ANTX N/A
- Revenue Next Year
- GORV $20.54
- ANTX N/A
- P/E Ratio
- GORV N/A
- ANTX N/A
- Revenue Growth
- GORV N/A
- ANTX N/A
- 52 Week Low
- GORV $0.13
- ANTX $0.87
- 52 Week High
- GORV $3.75
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- GORV 51.90
- ANTX 42.08
- Support Level
- GORV $0.25
- ANTX $1.06
- Resistance Level
- GORV $0.29
- ANTX $1.14
- Average True Range (ATR)
- GORV 0.06
- ANTX 0.06
- MACD
- GORV 0.01
- ANTX -0.01
- Stochastic Oscillator
- GORV 34.45
- ANTX 43.48
About GORV Lazydays Holdings Inc.
Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.